Global New Psychoactive Substance Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 115
Published Date: 10 Jan 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global New Psychoactive Substance market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the New Psychoactive Substance industry chain, the market status of Cancer (Stimulants, Cannabinoids), Neuropathic Disorders (Stimulants, Cannabinoids), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of New Psychoactive Substance.
Regionally, the report analyzes the New Psychoactive Substance markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global New Psychoactive Substance market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the New Psychoactive Substance market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the New Psychoactive Substance industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Stimulants, Cannabinoids).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the New Psychoactive Substance market.
Regional Analysis: The report involves examining the New Psychoactive Substance market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the New Psychoactive Substance market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to New Psychoactive Substance:
Company Analysis: Report covers individual New Psychoactive Substance players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards New Psychoactive Substance This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancer, Neuropathic Disorders).
Technology Analysis: Report covers specific technologies relevant to New Psychoactive Substance. It assesses the current state, advancements, and potential future developments in New Psychoactive Substance areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the New Psychoactive Substance market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
New Psychoactive Substance market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Stimulants
Cannabinoids
Hallucinogens
Depressants
Market segment by Application
Cancer
Neuropathic Disorders
Spasticity
Others
Market segment by players, this report covers
Zynerba Pharmaceuticals
GW Pharmaceuticals
Teewinot Life Sciences
AusCann
Cannabics Pharmaceuticals
Tilray
Cyrelian
Anandia Laboratories
InMed Pharmaceuticals
Renew Biopharma
Cronos Group
ICC International Cannabis
Biotii Technologies
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe New Psychoactive Substance product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of New Psychoactive Substance, with revenue, gross margin and global market share of New Psychoactive Substance from 2019 to 2024.
Chapter 3, the New Psychoactive Substance competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and New Psychoactive Substance market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of New Psychoactive Substance.
Chapter 13, to describe New Psychoactive Substance research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of New Psychoactive Substance
1.2 Market Estimation Caveats and Base Year
1.3 Classification of New Psychoactive Substance by Type
1.3.1 Overview: Global New Psychoactive Substance Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global New Psychoactive Substance Consumption Value Market Share by Type in 2023
1.3.3 Stimulants
1.3.4 Cannabinoids
1.3.5 Hallucinogens
1.3.6 Depressants
1.4 Global New Psychoactive Substance Market by Application
1.4.1 Overview: Global New Psychoactive Substance Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cancer
1.4.3 Neuropathic Disorders
1.4.4 Spasticity
1.4.5 Others
1.5 Global New Psychoactive Substance Market Size & Forecast
1.6 Global New Psychoactive Substance Market Size and Forecast by Region
1.6.1 Global New Psychoactive Substance Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global New Psychoactive Substance Market Size by Region, (2019-2030)
1.6.3 North America New Psychoactive Substance Market Size and Prospect (2019-2030)
1.6.4 Europe New Psychoactive Substance Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific New Psychoactive Substance Market Size and Prospect (2019-2030)
1.6.6 South America New Psychoactive Substance Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa New Psychoactive Substance Market Size and Prospect (2019-2030)
2.1 Zynerba Pharmaceuticals
2.1.1 Zynerba Pharmaceuticals Details
2.1.2 Zynerba Pharmaceuticals Major Business
2.1.3 Zynerba Pharmaceuticals New Psychoactive Substance Product and Solutions
2.1.4 Zynerba Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Zynerba Pharmaceuticals Recent Developments and Future Plans
2.2 GW Pharmaceuticals
2.2.1 GW Pharmaceuticals Details
2.2.2 GW Pharmaceuticals Major Business
2.2.3 GW Pharmaceuticals New Psychoactive Substance Product and Solutions
2.2.4 GW Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GW Pharmaceuticals Recent Developments and Future Plans
2.3 Teewinot Life Sciences
2.3.1 Teewinot Life Sciences Details
2.3.2 Teewinot Life Sciences Major Business
2.3.3 Teewinot Life Sciences New Psychoactive Substance Product and Solutions
2.3.4 Teewinot Life Sciences New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Teewinot Life Sciences Recent Developments and Future Plans
2.4 AusCann
2.4.1 AusCann Details
2.4.2 AusCann Major Business
2.4.3 AusCann New Psychoactive Substance Product and Solutions
2.4.4 AusCann New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 AusCann Recent Developments and Future Plans
2.5 Cannabics Pharmaceuticals
2.5.1 Cannabics Pharmaceuticals Details
2.5.2 Cannabics Pharmaceuticals Major Business
2.5.3 Cannabics Pharmaceuticals New Psychoactive Substance Product and Solutions
2.5.4 Cannabics Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Cannabics Pharmaceuticals Recent Developments and Future Plans
2.6 Tilray
2.6.1 Tilray Details
2.6.2 Tilray Major Business
2.6.3 Tilray New Psychoactive Substance Product and Solutions
2.6.4 Tilray New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Tilray Recent Developments and Future Plans
2.7 Cyrelian
2.7.1 Cyrelian Details
2.7.2 Cyrelian Major Business
2.7.3 Cyrelian New Psychoactive Substance Product and Solutions
2.7.4 Cyrelian New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Cyrelian Recent Developments and Future Plans
2.8 Anandia Laboratories
2.8.1 Anandia Laboratories Details
2.8.2 Anandia Laboratories Major Business
2.8.3 Anandia Laboratories New Psychoactive Substance Product and Solutions
2.8.4 Anandia Laboratories New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Anandia Laboratories Recent Developments and Future Plans
2.9 InMed Pharmaceuticals
2.9.1 InMed Pharmaceuticals Details
2.9.2 InMed Pharmaceuticals Major Business
2.9.3 InMed Pharmaceuticals New Psychoactive Substance Product and Solutions
2.9.4 InMed Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 InMed Pharmaceuticals Recent Developments and Future Plans
2.10 Renew Biopharma
2.10.1 Renew Biopharma Details
2.10.2 Renew Biopharma Major Business
2.10.3 Renew Biopharma New Psychoactive Substance Product and Solutions
2.10.4 Renew Biopharma New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Renew Biopharma Recent Developments and Future Plans
2.11 Cronos Group
2.11.1 Cronos Group Details
2.11.2 Cronos Group Major Business
2.11.3 Cronos Group New Psychoactive Substance Product and Solutions
2.11.4 Cronos Group New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Cronos Group Recent Developments and Future Plans
2.12 ICC International Cannabis
2.12.1 ICC International Cannabis Details
2.12.2 ICC International Cannabis Major Business
2.12.3 ICC International Cannabis New Psychoactive Substance Product and Solutions
2.12.4 ICC International Cannabis New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 ICC International Cannabis Recent Developments and Future Plans
2.13 Biotii Technologies
2.13.1 Biotii Technologies Details
2.13.2 Biotii Technologies Major Business
2.13.3 Biotii Technologies New Psychoactive Substance Product and Solutions
2.13.4 Biotii Technologies New Psychoactive Substance Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Biotii Technologies Recent Developments and Future Plans
3.1 Global New Psychoactive Substance Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of New Psychoactive Substance by Company Revenue
3.2.2 Top 3 New Psychoactive Substance Players Market Share in 2023
3.2.3 Top 6 New Psychoactive Substance Players Market Share in 2023
3.3 New Psychoactive Substance Market: Overall Company Footprint Analysis
3.3.1 New Psychoactive Substance Market: Region Footprint
3.3.2 New Psychoactive Substance Market: Company Product Type Footprint
3.3.3 New Psychoactive Substance Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global New Psychoactive Substance Consumption Value and Market Share by Type (2019-2024)
4.2 Global New Psychoactive Substance Market Forecast by Type (2025-2030)
5.1 Global New Psychoactive Substance Consumption Value Market Share by Application (2019-2024)
5.2 Global New Psychoactive Substance Market Forecast by Application (2025-2030)
6.1 North America New Psychoactive Substance Consumption Value by Type (2019-2030)
6.2 North America New Psychoactive Substance Consumption Value by Application (2019-2030)
6.3 North America New Psychoactive Substance Market Size by Country
6.3.1 North America New Psychoactive Substance Consumption Value by Country (2019-2030)
6.3.2 United States New Psychoactive Substance Market Size and Forecast (2019-2030)
6.3.3 Canada New Psychoactive Substance Market Size and Forecast (2019-2030)
6.3.4 Mexico New Psychoactive Substance Market Size and Forecast (2019-2030)
7.1 Europe New Psychoactive Substance Consumption Value by Type (2019-2030)
7.2 Europe New Psychoactive Substance Consumption Value by Application (2019-2030)
7.3 Europe New Psychoactive Substance Market Size by Country
7.3.1 Europe New Psychoactive Substance Consumption Value by Country (2019-2030)
7.3.2 Germany New Psychoactive Substance Market Size and Forecast (2019-2030)
7.3.3 France New Psychoactive Substance Market Size and Forecast (2019-2030)
7.3.4 United Kingdom New Psychoactive Substance Market Size and Forecast (2019-2030)
7.3.5 Russia New Psychoactive Substance Market Size and Forecast (2019-2030)
7.3.6 Italy New Psychoactive Substance Market Size and Forecast (2019-2030)
8.1 Asia-Pacific New Psychoactive Substance Consumption Value by Type (2019-2030)
8.2 Asia-Pacific New Psychoactive Substance Consumption Value by Application (2019-2030)
8.3 Asia-Pacific New Psychoactive Substance Market Size by Region
8.3.1 Asia-Pacific New Psychoactive Substance Consumption Value by Region (2019-2030)
8.3.2 China New Psychoactive Substance Market Size and Forecast (2019-2030)
8.3.3 Japan New Psychoactive Substance Market Size and Forecast (2019-2030)
8.3.4 South Korea New Psychoactive Substance Market Size and Forecast (2019-2030)
8.3.5 India New Psychoactive Substance Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia New Psychoactive Substance Market Size and Forecast (2019-2030)
8.3.7 Australia New Psychoactive Substance Market Size and Forecast (2019-2030)
9.1 South America New Psychoactive Substance Consumption Value by Type (2019-2030)
9.2 South America New Psychoactive Substance Consumption Value by Application (2019-2030)
9.3 South America New Psychoactive Substance Market Size by Country
9.3.1 South America New Psychoactive Substance Consumption Value by Country (2019-2030)
9.3.2 Brazil New Psychoactive Substance Market Size and Forecast (2019-2030)
9.3.3 Argentina New Psychoactive Substance Market Size and Forecast (2019-2030)
10.1 Middle East & Africa New Psychoactive Substance Consumption Value by Type (2019-2030)
10.2 Middle East & Africa New Psychoactive Substance Consumption Value by Application (2019-2030)
10.3 Middle East & Africa New Psychoactive Substance Market Size by Country
10.3.1 Middle East & Africa New Psychoactive Substance Consumption Value by Country (2019-2030)
10.3.2 Turkey New Psychoactive Substance Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia New Psychoactive Substance Market Size and Forecast (2019-2030)
10.3.4 UAE New Psychoactive Substance Market Size and Forecast (2019-2030)
11.1 New Psychoactive Substance Market Drivers
11.2 New Psychoactive Substance Market Restraints
11.3 New Psychoactive Substance Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 New Psychoactive Substance Industry Chain
12.2 New Psychoactive Substance Upstream Analysis
12.3 New Psychoactive Substance Midstream Analysis
12.4 New Psychoactive Substance Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global New Psychoactive Substance Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global New Psychoactive Substance Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global New Psychoactive Substance Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global New Psychoactive Substance Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Zynerba Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 6. Zynerba Pharmaceuticals Major Business
Table 7. Zynerba Pharmaceuticals New Psychoactive Substance Product and Solutions
Table 8. Zynerba Pharmaceuticals New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Zynerba Pharmaceuticals Recent Developments and Future Plans
Table 10. GW Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 11. GW Pharmaceuticals Major Business
Table 12. GW Pharmaceuticals New Psychoactive Substance Product and Solutions
Table 13. GW Pharmaceuticals New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. GW Pharmaceuticals Recent Developments and Future Plans
Table 15. Teewinot Life Sciences Company Information, Head Office, and Major Competitors
Table 16. Teewinot Life Sciences Major Business
Table 17. Teewinot Life Sciences New Psychoactive Substance Product and Solutions
Table 18. Teewinot Life Sciences New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Teewinot Life Sciences Recent Developments and Future Plans
Table 20. AusCann Company Information, Head Office, and Major Competitors
Table 21. AusCann Major Business
Table 22. AusCann New Psychoactive Substance Product and Solutions
Table 23. AusCann New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. AusCann Recent Developments and Future Plans
Table 25. Cannabics Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 26. Cannabics Pharmaceuticals Major Business
Table 27. Cannabics Pharmaceuticals New Psychoactive Substance Product and Solutions
Table 28. Cannabics Pharmaceuticals New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Cannabics Pharmaceuticals Recent Developments and Future Plans
Table 30. Tilray Company Information, Head Office, and Major Competitors
Table 31. Tilray Major Business
Table 32. Tilray New Psychoactive Substance Product and Solutions
Table 33. Tilray New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Tilray Recent Developments and Future Plans
Table 35. Cyrelian Company Information, Head Office, and Major Competitors
Table 36. Cyrelian Major Business
Table 37. Cyrelian New Psychoactive Substance Product and Solutions
Table 38. Cyrelian New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Cyrelian Recent Developments and Future Plans
Table 40. Anandia Laboratories Company Information, Head Office, and Major Competitors
Table 41. Anandia Laboratories Major Business
Table 42. Anandia Laboratories New Psychoactive Substance Product and Solutions
Table 43. Anandia Laboratories New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Anandia Laboratories Recent Developments and Future Plans
Table 45. InMed Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 46. InMed Pharmaceuticals Major Business
Table 47. InMed Pharmaceuticals New Psychoactive Substance Product and Solutions
Table 48. InMed Pharmaceuticals New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. InMed Pharmaceuticals Recent Developments and Future Plans
Table 50. Renew Biopharma Company Information, Head Office, and Major Competitors
Table 51. Renew Biopharma Major Business
Table 52. Renew Biopharma New Psychoactive Substance Product and Solutions
Table 53. Renew Biopharma New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Renew Biopharma Recent Developments and Future Plans
Table 55. Cronos Group Company Information, Head Office, and Major Competitors
Table 56. Cronos Group Major Business
Table 57. Cronos Group New Psychoactive Substance Product and Solutions
Table 58. Cronos Group New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Cronos Group Recent Developments and Future Plans
Table 60. ICC International Cannabis Company Information, Head Office, and Major Competitors
Table 61. ICC International Cannabis Major Business
Table 62. ICC International Cannabis New Psychoactive Substance Product and Solutions
Table 63. ICC International Cannabis New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. ICC International Cannabis Recent Developments and Future Plans
Table 65. Biotii Technologies Company Information, Head Office, and Major Competitors
Table 66. Biotii Technologies Major Business
Table 67. Biotii Technologies New Psychoactive Substance Product and Solutions
Table 68. Biotii Technologies New Psychoactive Substance Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Biotii Technologies Recent Developments and Future Plans
Table 70. Global New Psychoactive Substance Revenue (USD Million) by Players (2019-2024)
Table 71. Global New Psychoactive Substance Revenue Share by Players (2019-2024)
Table 72. Breakdown of New Psychoactive Substance by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in New Psychoactive Substance, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 74. Head Office of Key New Psychoactive Substance Players
Table 75. New Psychoactive Substance Market: Company Product Type Footprint
Table 76. New Psychoactive Substance Market: Company Product Application Footprint
Table 77. New Psychoactive Substance New Market Entrants and Barriers to Market Entry
Table 78. New Psychoactive Substance Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global New Psychoactive Substance Consumption Value (USD Million) by Type (2019-2024)
Table 80. Global New Psychoactive Substance Consumption Value Share by Type (2019-2024)
Table 81. Global New Psychoactive Substance Consumption Value Forecast by Type (2025-2030)
Table 82. Global New Psychoactive Substance Consumption Value by Application (2019-2024)
Table 83. Global New Psychoactive Substance Consumption Value Forecast by Application (2025-2030)
Table 84. North America New Psychoactive Substance Consumption Value by Type (2019-2024) & (USD Million)
Table 85. North America New Psychoactive Substance Consumption Value by Type (2025-2030) & (USD Million)
Table 86. North America New Psychoactive Substance Consumption Value by Application (2019-2024) & (USD Million)
Table 87. North America New Psychoactive Substance Consumption Value by Application (2025-2030) & (USD Million)
Table 88. North America New Psychoactive Substance Consumption Value by Country (2019-2024) & (USD Million)
Table 89. North America New Psychoactive Substance Consumption Value by Country (2025-2030) & (USD Million)
Table 90. Europe New Psychoactive Substance Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Europe New Psychoactive Substance Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Europe New Psychoactive Substance Consumption Value by Application (2019-2024) & (USD Million)
Table 93. Europe New Psychoactive Substance Consumption Value by Application (2025-2030) & (USD Million)
Table 94. Europe New Psychoactive Substance Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe New Psychoactive Substance Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific New Psychoactive Substance Consumption Value by Type (2019-2024) & (USD Million)
Table 97. Asia-Pacific New Psychoactive Substance Consumption Value by Type (2025-2030) & (USD Million)
Table 98. Asia-Pacific New Psychoactive Substance Consumption Value by Application (2019-2024) & (USD Million)
Table 99. Asia-Pacific New Psychoactive Substance Consumption Value by Application (2025-2030) & (USD Million)
Table 100. Asia-Pacific New Psychoactive Substance Consumption Value by Region (2019-2024) & (USD Million)
Table 101. Asia-Pacific New Psychoactive Substance Consumption Value by Region (2025-2030) & (USD Million)
Table 102. South America New Psychoactive Substance Consumption Value by Type (2019-2024) & (USD Million)
Table 103. South America New Psychoactive Substance Consumption Value by Type (2025-2030) & (USD Million)
Table 104. South America New Psychoactive Substance Consumption Value by Application (2019-2024) & (USD Million)
Table 105. South America New Psychoactive Substance Consumption Value by Application (2025-2030) & (USD Million)
Table 106. South America New Psychoactive Substance Consumption Value by Country (2019-2024) & (USD Million)
Table 107. South America New Psychoactive Substance Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Middle East & Africa New Psychoactive Substance Consumption Value by Type (2019-2024) & (USD Million)
Table 109. Middle East & Africa New Psychoactive Substance Consumption Value by Type (2025-2030) & (USD Million)
Table 110. Middle East & Africa New Psychoactive Substance Consumption Value by Application (2019-2024) & (USD Million)
Table 111. Middle East & Africa New Psychoactive Substance Consumption Value by Application (2025-2030) & (USD Million)
Table 112. Middle East & Africa New Psychoactive Substance Consumption Value by Country (2019-2024) & (USD Million)
Table 113. Middle East & Africa New Psychoactive Substance Consumption Value by Country (2025-2030) & (USD Million)
Table 114. New Psychoactive Substance Raw Material
Table 115. Key Suppliers of New Psychoactive Substance Raw Materials
List of Figures
Figure 1. New Psychoactive Substance Picture
Figure 2. Global New Psychoactive Substance Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global New Psychoactive Substance Consumption Value Market Share by Type in 2023
Figure 4. Stimulants
Figure 5. Cannabinoids
Figure 6. Hallucinogens
Figure 7. Depressants
Figure 8. Global New Psychoactive Substance Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. New Psychoactive Substance Consumption Value Market Share by Application in 2023
Figure 10. Cancer Picture
Figure 11. Neuropathic Disorders Picture
Figure 12. Spasticity Picture
Figure 13. Others Picture
Figure 14. Global New Psychoactive Substance Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global New Psychoactive Substance Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market New Psychoactive Substance Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global New Psychoactive Substance Consumption Value Market Share by Region (2019-2030)
Figure 18. Global New Psychoactive Substance Consumption Value Market Share by Region in 2023
Figure 19. North America New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 22. South America New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 24. Global New Psychoactive Substance Revenue Share by Players in 2023
Figure 25. New Psychoactive Substance Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players New Psychoactive Substance Market Share in 2023
Figure 27. Global Top 6 Players New Psychoactive Substance Market Share in 2023
Figure 28. Global New Psychoactive Substance Consumption Value Share by Type (2019-2024)
Figure 29. Global New Psychoactive Substance Market Share Forecast by Type (2025-2030)
Figure 30. Global New Psychoactive Substance Consumption Value Share by Application (2019-2024)
Figure 31. Global New Psychoactive Substance Market Share Forecast by Application (2025-2030)
Figure 32. North America New Psychoactive Substance Consumption Value Market Share by Type (2019-2030)
Figure 33. North America New Psychoactive Substance Consumption Value Market Share by Application (2019-2030)
Figure 34. North America New Psychoactive Substance Consumption Value Market Share by Country (2019-2030)
Figure 35. United States New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe New Psychoactive Substance Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe New Psychoactive Substance Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe New Psychoactive Substance Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 42. France New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific New Psychoactive Substance Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific New Psychoactive Substance Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific New Psychoactive Substance Consumption Value Market Share by Region (2019-2030)
Figure 49. China New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 52. India New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 55. South America New Psychoactive Substance Consumption Value Market Share by Type (2019-2030)
Figure 56. South America New Psychoactive Substance Consumption Value Market Share by Application (2019-2030)
Figure 57. South America New Psychoactive Substance Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa New Psychoactive Substance Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa New Psychoactive Substance Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa New Psychoactive Substance Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE New Psychoactive Substance Consumption Value (2019-2030) & (USD Million)
Figure 66. New Psychoactive Substance Market Drivers
Figure 67. New Psychoactive Substance Market Restraints
Figure 68. New Psychoactive Substance Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of New Psychoactive Substance in 2023
Figure 71. Manufacturing Process Analysis of New Psychoactive Substance
Figure 72. New Psychoactive Substance Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Zynerba Pharmaceuticals GW Pharmaceuticals Teewinot Life Sciences AusCann Cannabics Pharmaceuticals Tilray Cyrelian Anandia Laboratories InMed Pharmaceuticals Renew Biopharma Cronos Group ICC International Cannabis Biotii Technologies
Related Reports
08 Sep 2021
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
